Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma

  • Andrew J. Cowan, Phillip A. Stevenson, Ted A. Gooley, Shani L. Frayo, George R. Oliveira, Stephen D. Smith, Damian J. Green, Jennifer E. Roden, John M. Pagel, Brent L. Wood, Oliver W. Press, Ajay K. Gopal
  • British Journal of Haematology, January 2017, Wiley
  • DOI: 10.1111/bjh.14451

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/bjh.14451

In partnership with: